VAP-1-deficient mice display defects in mucosal immunity and antimicrobial responses: Implications for antiadhesive applications

Journal of Immunology

Volumn 179, Issue 9, 2007, Pages 6160-6168

  Koskinen, Kaisa ^a,b,c   Nevalainen, Suvi ^a,c   Karikoski, Marika ^a,b,c   Hänninen, Arno ^b   Jalkanen, Sirpa ^a,b,c   Salmi, Marko ^a,c  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); BTT 2052; CD11 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR; HYDRAZINE DERIVATIVE; IMMUNOGLOBULIN A; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOAMINE OXIDASE INHIBITOR; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; OVALBUMIN; UNCLASSIFIED DRUG; VASCULAR ADHESION PROTEIN 1; VASCULAR ADHESION PROTEIN 1 ANTIBODY; HOMING RECEPTOR; SEMICARBAZIDE SENSITIVE AMINE OXIDASE VASCULAR ADHESION PROTEIN 1, MOUSE; SEMICARBAZIDE-SENSITIVE AMINE OXIDASE-VASCULAR ADHESION PROTEIN-1, MOUSE; STAPHYLOCOCCUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ANTIGEN EXPRESSION; ANTIMICROBIAL ACTIVITY; ARTICLE; B LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; COXSACKIE VIRUS B4; COXSACKIE VIRUS INFECTION; FEMALE; GENE DELETION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPHENOTYPING; INFECTION RISK; LEUKOCYTE; LYMPHOCYTE HOMING; LYMPHOCYTE MIGRATION; MICROBIAL IMMUNITY; MOUSE; MOUSE STRAIN; MUCOSAL IMMUNITY; NONHUMAN; ONSET AGE; PEYER PATCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; T LYMPHOCYTE; WILD TYPE; ANIMAL; BACTERIUM ADHERENCE; BLOOD; C57BL MOUSE; CYTOLOGY; GENETICS; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE COUNT; LYMPHOID TISSUE; METABOLISM; MOUSE MUTANT; PATHOLOGY;

AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; BACTERIAL ADHESION; CELL ADHESION MOLECULES; COXSACKIEVIRUS INFECTIONS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; LYMPHOCYTE COUNT; LYMPHOCYTES; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEYER'S PATCHES; RECEPTORS, LYMPHOCYTE HOMING; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS;

EID: 38449117853     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.9.6160     Document Type: Article

References (49)

1. Von Andrian, U. H., and T. R. Mempel. 2003. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3: 867-878.
2. Kunkel, E. J., and E. C. Butcher. 2002. Chemokines and the tissue-specific migration of lymphocytes. Immunity 16: 1-4.
3. Salmi, M., and S. Jalkanen. 1992. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 257: 1407-1409.
4. Smith, D. J., M. Salmi, P. Bono, J. Hellman, T. Leu, and S. Jalkanen. 1998. Cloning of vascular adhesion protein-1 reveals a novel multifunctional adhesion molecule. J. Exp. Med. 188: 17-27.
5. Jalkanen, S., and M. Salmi. 2001. Cell surface monoamine oxidases: enzymes in search of a function. EMBO J. 20: 3893-3901.
6. Reth, M. 2002. Hydrogen peroxide as second messenger in lymphocyte activation. Nat. Immunol. 3: 1129-1134.
7. Stone, J. R., and S. Yang. 2006. Hydrogen peroxide: a signaling messenger. Antioxid. Redox. Signal. 8: 243-270.
8. Salmi, M., and S. Jalkanen. 1996. Human vascular adhesion protein-1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells. J. Exp. Med. 183: 569-579.
9. Salmi, M., G. Yegutkin, R. Lehvonen, K. Koskinen, T. Salminen, and S. Jalkanen. 2001. A cell surface amine oxidase directly controls lymphocyte migration. Immunity 14: 265-276.
10. Bonder, C., M. G. Swain, L. D. Zbytnuik, M. U. Norman, J. Yamanouchi, P. Santamaria, M. Ajuebor, M. Salmi, S. Jalkanen, and P. Kubes. 2005. Rules of recruitment of trafficking Th1 and Th2 cells in inflamed liver. Immunity 23: 153-163.
11. Tohka, S., M.-L. Laukkanen, S. Jalkanen, and M. Salmi. 2001. Vascular adhesion protein 1 (VAP-1) functions as a molecular brake during granulocyte rolling and mediates their recruitment in vivo. FASEB J. 15: 373-382.
12. Koskinen, K., P. J. Vainio, D. J. Smith, M. Pihlavisto, S. Yla-Herttuala, S. Jalkanen, and M. Salmi. 2004. Granulocyte transmigration through endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1). Blood 103: 3388-3395.
13. Merinen, M., H. Irjala, M. Salmi, I. Jaakkola, A. Hanninen, and S. Jalkanen. 2005. Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse. Am. J. Pathol. 166: 793-800.
14. Martelius, T., V. Salaspuro, M. Salmi, L. Krogerus, K. Hockerstedt, S. Jalkanen, and I. Lautenschlager. 2004. Blockade of vascular adhesion protein-1 inhibits lymphocyte infiltration in rat liver allograft rejection. Am. J. Pathol. 165: 1993-2001.
15. Lalor, P. F., S. Edwards, G. McNab, M. Salmi, S. Jalkanen, and D. H. Adams. 2002. Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells. J. Immunol. 169: 983-992.
16. Stolen, C. M., F. Marttila-Ichihara, K. Koskinen, G. G. Yegutkin, R. Turja, P. Bono, M. Skurnik, A. Hanninen, S. Jalkanen, and M. Salmi. 2005. Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo. Immunity 22: 105-115.
17. Vainio, P. J., O. Kortekangas-Savolainen, J. H. Mikkola, K. Jaakkola, K. Kalimo, S. Jalkanen, and T. Veromaa. 2005. Safety of blocking vascular adhesion protein-1 in patients with contact dermatitis. Basic Clin. Pharmacol. Toxicol. 96: 429-435.
18. Salter-Cid, L. M., E. Wang, A. M. O'Rourke, A. Miller, H. Gao, L. Huang, A. Garcia, and M. D. Linnik. 2005. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase. J. Pharmacol. Exp. Ther. 315: 553-562.
19. Enioutina, E. Y., D. M. Visic, and R. A. Daynes. 2002. The induction of systemic and mucosal immunity to protein vaccines delivered through skin sites exposed to UVB. Vaccine 20: 2116-2130.
20. Kantele, A. 1990. Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine. Vaccine 8: 321-326.
21. Nieminen, M., T. Henttinen, M. Merinen, F. Marttila-Ichihara, J. E. Eriksson, and S. Jalkanen. 2006. Vimentin function in lymphocyte adhesion and transcellular migration. Nat. Cell. Biol. 8: 156-162.
22. Vajdy, M., M. H. Kosco-Vilbois, M. Kopf, G. Kohler, and N. Lycke. 1995. Impaired mucosal immune responses in interleukin 4-targeted mice. J. Exp. Med. 181: 41-53.
23. Hanninen, A., N. R. Martinez, G. M. Davey, W. R. Heath, and L. C. Harrison. 2002. Transient blockade of CD40 ligand dissociates pathogenic from protective mucosal immunity. J. Clin. Invest. 109: 261-267.
24. Boyle, J. S., A. Silva, J. L. Brady, and A. M. Lew. 1997. DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity. Proc. Natl. Acad. Sci. USA 94: 14626-14631.
25. Francis, K. P., D. Joh, C. Bellinger-Kawahara, M. J. Hawkinson, T. F. Purchio, and P. R. Contag. 2000. Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect. Immun. 68: 3594-3600.
26. Hindersson, M., A. Orn, R. A. Harris, and G. Frisk. 2004. Strains of coxsackie virus B4 differed in their ability to induce acute pancreatitis and the responses were negatively correlated to glucose tolerance. Arch. Virol. 149: 1985-2000.
27. Toniolo, A., T. Onodera, G. Jordan, J. W. Yoon, and A. L. Notkins. 1982. Virus-induced diabetes mellitus: glucose abnormalities produced in mice by the six members of the Coxsackie B virus group. Diabetes 31: 496-499.
28. Al-Hello, H., B. Davydova, T. Smura, S. Kaialainen, P. Ylipaasto, E. Saario, T. Hovi, E. Rieder, and M. Roivainen. 2005. Phenotypic and genetic changes in coxsackievirus B5 following repeated passage in mouse pancreas in vivo. J. Med. Virol. 75: 566-574.
29. Marttila-Ichihara, F., D. J. Smith, C. Stolen, G. G. Yegutkin, K. Elima, N. Mercier, R. Kiviranta, M. Pihlavisto, S. Alaranta, U. Pentikainen, et al. 2006. Vascular amine oxidases are needed for leukocyte extravasation into inflamed joints in vivo. Arthritis Rheum. 54: 2852-2862.
30. Linton, P. J., and K. Dorshkind. 2004. Age-related changes in lymphocyte development and function. Nat. Immunol. 5: 133-139.
31. Miller, R. A., S. B. Berger, D. T. Burke, A. Galecki, G. G. Garcia, J. M. Harper, and A. A. Sadighi Akha. 2005. T cells in aging mice: genetic, developmental, and biochemical analyses. Immunol. Rev. 205: 94-103.
32. Frasca, D., R. L. Riley, and B. B. Blomberg. 2005. Humoral immune response and B cell functions including immunoglobulin class switch are downregulated in aged mice and humans. Semin. Immunol. 17: 378-384.
33. Brandtzaeg, P., and F. E. Johansen. 2005. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol. Rev. 206: 32-63.
34. Kunkel, E. J., and E. C. Butcher. 2003. Plasma-cell homing. Nat. Rev. Immunol. 3: 822-829.
35. Irish, J. M., D. K. Czerwinski, G. P. Nolan, and R. Levy. 2006. Kinetics of B cell receptor signaling in human B cell subsets mapped by phosphospecific flow cytometry. J. Immunol. 177: 1581-1589.
36. Lalor, P. F., P. J. Sun, C. J. Weston, A. Martin-Santos, M. J. Wakelam, and D. H. Adams. 2007. Activation of vascular adhesion protein-1 on liver endothelium results in an NF-κB-dependent increase in lymphocyte adhesion. Hepatology 45: 465-474.
37. Jalkanen, S., M. Karikoski, N. Mercier, K. Koskinen, T. Henttinen, K. Elima, K. Salmivirta, and M. Salmi. 2007. The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding. Blood 110: 1864-1870.
38. Frenette, P. S., T. N. Mayadas, H. Rayburn, R. O. Hynes, and D. D. Wagner. 1996. Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell 84: 563-574.
39. Seiler, K. P., Y. Ma, J. H. Weis, P. S. Frenette, R. O. Hynes, D. D. Wagner, and J. J. Weis. 1998. E and P selectins are not required for resistance to severe murine lyme arthritis. Infect. Immun. 66: 4557-4559.
40. Wickel, D. J., M. Mercer-Jones, J. C. Peyton, M. S. Shrotri, and W. G. Cheadle. 1998. Neutrophil migration into the peritoneum is P-selectin dependent, but sequestration in lungs is selectin independent during peritonitis. Shock 10: 265-269.
41. Kawashima, N., R. Niederman, R. O. Hynes, M. Ullmann-Cullere, and P. Stashenko. 1999. Infection-stimulated infraosseus inflammation and bone destruction is increased in P-/E-selectin knockout mice. Immunology 97: 117-123.
42. Verdrengh, M., H. Erlandsson-Harris, and A. Tarkowski. 2000. Role of selectins in experimental Staphylococcus aureus-induced arthritis. Eur. J. Immunol. 30: 1606-1613.
43. Baker, P. J., L. DuFour, M. Dixon, and D. C. Roopenian. 2000. Adhesion molecule deficiencies increase Porphyromonas gingivalis-induced alveolar bone loss in mice. Infect. Immun. 68: 3103-3107.
44. Chang, W. L., J. Li, G. Sun, H. L. Chen, R. D. Specian, S. M. Berney, D. N. Granger, and H. C. van der Heyde. 2003. P-selectin contributes to severe experimental malaria but is not required for leukocyte adhesion to brain microvasculature. Infect. Immun. 71: 1911-1918.
45. Munoz, F. M., E. P. Hawkins, D. C. Bullard, A. L. Beaudet, and S. L. Kaplan. 1997. Host defense against systemic infection with Streptococcus pneumoniae is impaired in E-, P-, and E-/P-selectin-deficient mice. J. Clin. Invest. 100: 2099-2106.
46. Steinhoff, U., U. Klemm, M. Greiner, K. Bordasch, and S. H. Kaufmann. 1998. Altered intestinal immune system but normal antibacterial resistance in the absence of P-selectin and ICAM-1. J. Immunol. 160: 6112-6120.
47. + T lymphocytes to sites of viral infection does not require endothelial selectins. Blood 95: 1362-1369.
48. Zaph, C., and P. Scott. 2003. Th1 cell-mediated resistance to cutaneous infection with Leishmania major is independent of P- and E-selectins. J. Immunol. 171: 4726-4732.
49. Berger, J. R., and I. J. Koralnik. 2005. Progressive multifocal leukoencephalopathy and natalizumab- unforeseen consequences. N. Engl. J. Med. 353: 414-416.